Pharma Beat
Ed Silverman, Contributing Editor
June 5, 2013
There was a time when Merck was synonymous with innovative medicine. Now, though, the drug maker gets high marks for innovative marketing, but not much more. Consider the recent FDA approval of a new combination cholesterol pill that, instead of offe…
Read More »
Ed Silverman, Contributing Editor
April 3, 2013
SCOTUS to listen to state vs. federal pre-emption case on drug safety
Read More »
Ed Silverman, Contributing Editor
November 9, 2012
Could a meningitis outbreak have been prevented?
Read More »
Ed Silverman, Contributing Editor
October 11, 2012
How fast is too fast for drug approvals?
Read More »
Ed Silverman, Contributing Editor
September 6, 2012
Though the bribe be small, yet the fault is great
Read More »
Ed Silverman, Contributing Editor
July 18, 2012
The Middle Kingdom discovers compulsory licensing
Read More »
Ed Silverman, Contributing Editor
May 4, 2012
Will J&J and Novartis admit they face uphill climbs?
Read More »
Ed Silverman, Contributing Editor
March 7, 2012
Paula Deen as the cure — and cause — of diabetes?
Read More »
